These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19161874)

  • 1. Postnatal corticosteroids for bronchopulmonary dysplasia.
    Jobe AH
    Clin Perinatol; 2009 Mar; 36(1):177-88. PubMed ID: 19161874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - Who might benefit?
    Doyle LW; Cheong JLY
    Semin Fetal Neonatal Med; 2017 Oct; 22(5):290-295. PubMed ID: 28734731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia: Balancing the risks and benefits.
    Cheong JLY; Doyle LW
    Semin Fetal Neonatal Med; 2019 Jun; 24(3):197-201. PubMed ID: 30962159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging study.
    Raghuram K; Dunn M; Jangaard K; Reilly M; Asztalos E; Kelly E; Vincer M; Shah V
    BMC Pediatr; 2018 May; 18(1):153. PubMed ID: 29734948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia.
    Bassler D; van den Anker J
    Pediatr Clin North Am; 2017 Dec; 64(6):1355-1367. PubMed ID: 29173790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use.
    Grier DG; Halliday HL
    Drugs; 2005; 65(1):15-29. PubMed ID: 15610049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes.
    Cuna A; Lewis T; Dai H; Nyp M; Truog WE
    Pediatr Pulmonol; 2019 Feb; 54(2):165-170. PubMed ID: 30537393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia.
    Lim G; Lee BS; Choi YS; Park HW; Chung ML; Choi HJ; Kim EA; Kim KS
    Pediatr Neonatol; 2015 Aug; 56(4):261-7. PubMed ID: 25649722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids in the prevention and management of bronchopulmonary dysplasia.
    Grier DG; Halliday HL
    Semin Neonatol; 2003 Feb; 8(1):83-91. PubMed ID: 12667833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
    Watterberg KL;
    Pediatrics; 2010 Oct; 126(4):800-8. PubMed ID: 20819899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
    Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
    Pediatrics; 2006 Jan; 117(1):75-83. PubMed ID: 16396863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2010 Jan; (1):CD001146. PubMed ID: 20091516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in CRHR1 is associated with short-term respiratory response to corticosteroids in preterm infants at risk for bronchopulmonary dysplasia.
    Lewis T; Truog W; Norberg M; Ballard PL; Torgerson D;
    Pediatr Res; 2019 Apr; 85(5):625-633. PubMed ID: 30467342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minidex: very low dose dexamethasone (0.05 mg/kg/day) in chronic lung disease.
    Yates HL; Newell SJ
    Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F190-4. PubMed ID: 21115554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of corticosteroids and the outcome of infants with bronchopulmonary dysplasia.
    Mataloun MM; Gibelli MA; Kato AV; Vaz FA; Leone CR
    Rev Hosp Clin Fac Med Sao Paulo; 1999; 54(6):175-80. PubMed ID: 10881064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of inhaled steroids in the treatment of bronchopulmonary dysplasia.
    Avent ML; Gal P; Ransom JL
    Neonatal Netw; 1994 Apr; 13(3):63-9. PubMed ID: 7512192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reviewing the use of corticosteroids in bronchopulmonary dysplasia.
    de Oliveira Peixoto FA; Costa PS
    J Pediatr (Rio J); 2016; 92(2):122-8. PubMed ID: 26709507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia.
    Pantalitschka T; Poets CF
    Pediatr Pulmonol; 2006 Aug; 41(8):703-8. PubMed ID: 16779858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dexamethasone therapy on fibronectin and albumin levels in lung secretions of infants with bronchopulmonary dysplasia.
    Watts CL; Bruce MC
    J Pediatr; 1992 Oct; 121(4):597-607. PubMed ID: 1403398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.